xyzal 0.5 mg/ml oral solution
ucb (pharma) ireland limited - levocetirizine dihydrochloride - oral solution - 0.5 milligram(s)/millilitre - piperazine derivatives; levocetirizine
xyzal 5 mg film-coated tablets
ucb (pharma) ireland limited - levocetirizine dihydrochloride - film-coated tablet - 5 milligram(s) - piperazine derivatives; levocetirizine
zirtek 1 mg/ml oral solution
ucb (pharma) ireland limited - cetirizine dihydrochloride - oral solution - 1 milligram(s)/millilitre - piperazine derivatives; cetirizine
zirtek 10 mg film-coated tablets
ucb (pharma) ireland limited - cetirizine hydrochloride - film-coated tablet - 10 milligram(s) - piperazine derivatives; cetirizine
zirtek 10 mg/ml oral drops, solution
ucb (pharma) ireland limited - cetirizine dihydrochloride - oral drops, solution - 10 milligram(s)/millilitre - piperazine derivatives; cetirizine
zirtek plus decongestant 5mg/120mg prolonged release tablet
ucb (pharma) ireland limited - pseudoephedrine hydrochloride; cetirizine dihydrochloride - prolonged-release tablet - 5mg/120 milligram(s) - sympathomimetics; pseudoephedrine, combinations
neupro rotigotine 3 mg/24 hr transdermal patch sachet
ucb australia pty ltd t/a ucb pharma division of ucb australia - rotigotine, quantity: 6.75 mg - drug delivery system, transdermal - excipient ingredients: povidone; dl-alpha-tocopherol; sodium metabisulfite; ascorbyl palmitate; methylated trimethylated silica; heptane - parkinson's disease, neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic parkinson's disease from early stage to advanced disease. restless legs syndrome, neupro is indicated for the symptomatic treatment of moderate to severe idiopathic restless legs syndrome in adults.
neupro rotigotine 1 mg/24 hr transdermal patch sachet
ucb australia pty ltd t/a ucb pharma division of ucb australia - rotigotine, quantity: 2.25 mg - drug delivery system, transdermal - excipient ingredients: dl-alpha-tocopherol; povidone; ascorbyl palmitate; sodium metabisulfite; methylated trimethylated silica; heptane - parkinson's disease, neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic parkinson's disease from early stage to advanced disease. restless legs syndrome, neupro is indicated for the symptomatic treatment of moderate to severe idiopathic restless legs syndrome in adults.
tylex 30mg/500mg capsules
ucb pharma ltd - codeine phosphate; paracetamol - oral capsule - 30mg ; 500mg
tylex 30mg/500mg effervescent tablets
ucb pharma ltd - codeine phosphate; paracetamol - effervescent tablet - 30mg ; 500mg